🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementIs this normal?? My stomach is making SOUNDS — my results so far

Is this normal?? My stomach is making SOUNDS — my results so far

carl_compliance Wed, Oct 30, 2024 at 9:46 PM 38 replies 2,224 viewsPage 1 of 8
This thread is more than 19 months old. Information may be outdated. Consider searching for more recent discussions.
carl_compliance
Member
234
1,123
Nov 2024
Raleigh, NC
Oct 30, 2024 at 9:46 PM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

Trial-level incidence runs roughly 20 to 25% for nausea at the higher dose tiers and 12 to 17% for diarrhoea, with most events mild to moderate and concentrated in the weeks after each escalation.

What I am trying to establish is what distinguishes the nausea you can titrate through from the nausea that means stop.

Practical detail welcome, however dull — the duller the better.

46 16labquiet_amy, emily_PDX, Dr.SleepRoch and 43 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Oct 30, 2024 at 10:48 PM#2

This one has a reasonably settled answer, so here it is. Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Last edited: Oct 30, 2024 at 11:48 PM
45 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 42 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Oct 30, 2024 at 11:50 PM#3
JennaRN said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

Agreeing with JennaRN, and the qualification matters more than the agreement. The meal advice is right and incomplete without the hydration point. People stop drinking because drinking makes them feel full, then attribute dehydration symptoms to the drug.

Last edited: Oct 31, 2024 at 5:50 AM
44 14mona_PHX, andrew_nyc, Dr.EndoEP and 41 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Oct 31, 2024 at 12:52 AM#4
carl_compliance said:
The nausea I get is not really nausea, it is an aversion.

This matches mine closely enough to be worth saying so. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

43 13patPC_UT, Dr.DermMIA, fiona_VT and 40 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Oct 31, 2024 at 6:49 AM#5

Adding the clinical framing, because it changes how the question reads. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Last edited: Oct 31, 2024 at 12:49 PM
42 12emma_london, tammy_FL, Dr.LipidDallas and 39 others
Reply Quote Save Share Report
1238

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register